These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20869151)

  • 1. Lack of correlation between duration of osteonecrosis of the jaw and sequestra tissue morphology: what it tells us about the condition and what it means for future studies.
    Allen MR; Pandya B; Ruggiero SL
    J Oral Maxillofac Surg; 2010 Nov; 68(11):2730-4. PubMed ID: 20869151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S; Schmitz I; Tannapfel A; Eufinger H
    Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential pathophysiological mechanisms in osteonecrosis of the jaw.
    Landesberg R; Woo V; Cremers S; Cozin M; Marolt D; Vunjak-Novakovic G; Kousteni S; Raghavan S
    Ann N Y Acad Sci; 2011 Feb; 1218():62-79. PubMed ID: 21291478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome.
    Van den Wyngaert T; Claeys T; Huizing MT; Vermorken JB; Fossion E
    Ann Oncol; 2009 Feb; 20(2):331-6. PubMed ID: 18953067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
    Miksad RA; Lai KC; Dodson TB; Woo SB; Treister NS; Akinyemi O; Bihrle M; Maytal G; August M; Gazelle GS; Swan JS
    Oncologist; 2011; 16(1):121-32. PubMed ID: 21212433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis and osteonecrosis of the jaw (ONJ).
    Kim HK
    J Musculoskelet Neuronal Interact; 2007; 7(4):348-9. PubMed ID: 18094508
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
    Owosho AA; Blanchard A; Levi L; Kadempour A; Rosenberg H; Yom SK; Farooki A; Fornier M; Huryn JM; Estilo CL
    J Craniomaxillofac Surg; 2016 Mar; 44(3):265-70. PubMed ID: 26782845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
    La Verde N; Bareggi C; Garassino M; Borgonovo K; Sburlati P; Pedretti D; Bianchi C; Perrone S; Mihali D; Cobelli S; Mantica C; Rizzo A; Farina G
    Support Care Cancer; 2008 Nov; 16(11):1311-5. PubMed ID: 18663482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher bone matrix density exists in only a subset of patients with bisphosphonate-related osteonecrosis of the jaw.
    Allen MR; Ruggiero SL
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1373-7. PubMed ID: 19531405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.
    Raje N; Woo SB; Hande K; Yap JT; Richardson PG; Vallet S; Treister N; Hideshima T; Sheehy N; Chhetri S; Connell B; Xie W; Tai YT; Szot-Barnes A; Tian M; Schlossman RL; Weller E; Munshi NC; Van Den Abbeele AD; Anderson KC
    Clin Cancer Res; 2008 Apr; 14(8):2387-95. PubMed ID: 18413829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
    J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
    Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
    Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G; Pilolli GP; Maiorano E
    J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
    Van Poznak C; Estilo C
    Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.
    Almazrooa SA; Woo SB
    J Am Dent Assoc; 2009 Jul; 140(7):864-75. PubMed ID: 19571050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.